Alnylam Pharmaceuticals Inc (ALNY)
144.67
-1.39
(-0.95%)
USD |
NASDAQ |
Apr 24, 10:19
Alnylam Pharmaceuticals Gross Profit Margin (Quarterly): 80.47% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 80.47% |
| September 30, 2023 | 88.77% |
| June 30, 2023 | 73.22% |
| March 31, 2023 | 82.82% |
| December 31, 2022 | 84.70% |
| September 30, 2022 | 84.44% |
| June 30, 2022 | 81.85% |
| March 31, 2022 | 83.29% |
| December 31, 2021 | 85.43% |
| September 30, 2021 | 82.59% |
| June 30, 2021 | 82.43% |
| Date | Value |
|---|---|
| March 31, 2021 | 82.51% |
| December 31, 2020 | 85.92% |
| September 30, 2020 | 82.68% |
| June 30, 2020 | 80.83% |
| March 31, 2020 | 86.63% |
| December 31, 2019 | 83.01% |
| September 30, 2019 | 92.56% |
| June 30, 2019 | 90.33% |
| March 31, 2019 | 89.95% |
| December 31, 2018 | 92.08% |
| September 30, 2018 | 93.38% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
73.22%
Minimum
Jun 2023
92.56%
Maximum
Sep 2019
83.92%
Average
83.01%
Median
Dec 2019
Gross Profit Margin (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 99.06% |
| Pfizer Inc | 46.92% |
| Blueprint Medicines Corp | 99.64% |
| Madrigal Pharmaceuticals Inc | -- |
| Sarepta Therapeutics Inc | 88.87% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -12.22% |
| Return on Invested Capital | -56.70% |
| Profit Margin (Quarterly) | -31.35% |
| Operating Margin (Quarterly) | -26.47% |
| Return on Net Operating Assets | -39.69% |